AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (507.2 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?

Jiayi Deng1,2,*, Mingyi Yang1,2,*, Qing Zhou2 ( )
School of Medicine, South China University of Technology, Guangzhou 510006, China
Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China

*These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 22 Issue 1,
January 2025
Pages 21-27
DOI: 10.20892/j.issn.2095-3941.2024.0456

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Deng J, Yang M, Zhou Q. Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?. Cancer Biology & Medicine, 2025, 22(1): 21-27. https://doi.org/10.20892/j.issn.2095-3941.2024.0456

709

Views

85

Downloads

0

Crossref

4

Web of Science

5

Scopus
Received: 16 October 2024
Accepted: 03 December 2024
Published: 07 January 2025
©2025 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License